We recently published a list of Kevin O’Leary’s Stock Portfolio: 15 Stock Picks for 2025. In this article, we are going to ...

AD, The most common inflammatory skin disorder worldwide, is a highly heterogeneous condition with current treatments that do ...

Johnson & Johnson (NYSE:JNJ), a global healthcare giant, finds itself at a critical juncture as it navigates a complex landscape of opportunities and challenges. The company's recent performance and ...

One such company is Intuitive Surgical ( ISRG 0.11%). The medical device specialist's market cap currently tops $215 billion, ...

HistoSonics, a medical device company backed by Johnson & Johnson’s venture capital arm, is exploring the possibility of a U.S. initial ...

Barclays raised the firm’s price target on Johnson & Johnson to $166 from $159 and keeps an Equal Weight rating on the shares. The company ...

Johnson & Johnson ( JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to ...

Julie Whytock said she spent 26 weeks in hospital after her cancer diagnosis (Photo: supplied (left) Justin Sullivan/Getty ...

Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.

The institutional investor owned 43,167 shares of the company’s stock after purchasing an additional 2,058 shares during the period. Johnson & Johnson makes up approximately 1.6% of Ellsworth ...

Johnson & Johnson has a 12 month low of $140.68 and a 12 month high of $168.85. The company has a fifty day moving average price of $148.35 and a two-hundred day moving average price of $156.11.

Johnson & Johnson (JNJ ... were highlighted in the look-back and look-ahead on an earnings call, despite the company beating Wall Street expectations on revenue by $70 million and reporting ...